ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Essex Bio-Technology Ltd. ?
1
With ROE of 1.38%, it has a Very Expensive valuation with a 1.39 Price to Book Value
- Over the past year, while the stock has generated a return of 34.83%, its profits have risen by 197.5%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Essex Bio-Technology Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Essex Bio-Technology Ltd.
34.83%
0.95
55.74%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
24.35%
EBIT Growth (5y)
37.99%
EBIT to Interest (avg)
12.93
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.07
Tax Ratio
14.79%
Dividend Payout Ratio
22.16%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.02%
ROE (avg)
15.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
101
Industry P/E
Price to Book Value
1.39
EV to EBIT
84.87
EV to EBITDA
83.23
EV to Capital Employed
1.48
EV to Sales
17.48
PEG Ratio
NA
Dividend Yield
2.32%
ROCE (Latest)
1.74%
ROE (Latest)
1.38%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Essex Bio-Technology Ltd.
Debt-Equity Ratio
Lowest at -17.6 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.81% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Profit Margin
Highest at 24.53 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by 0.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At HKD 29.21 MM has Grown at 11.08%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Essex Bio-Technology Ltd.
Interest
At HKD 2.65 MM has Grown at 48.93%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
